Business Directory, Press Releases, Jobs, Products, Services, Articles
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | News on Your Site

Press Releases

botiss dental GmbH

Press Release

Receive press releases from botiss dental GmbH: By Email RSS Feeds:

botiss biomaterials Presents New Product Solutions for Specific Dental Indications

Berlin, Germany, March 19, 2015 --( During the IDS—the International Dentalshow in Cologne—berlin-based company botiss biomaterials GmbH has launched three innovative products: maxgraft® cortico®, a new version of the well-known mucoderm® matrix and collacone® max, an improved biomimetic composite cone. These were designed for particular dental indications such as shell, socket seal and socket preservation techniques.

maxgraft® cortico® is an allogenic bone plate that can be employed in place of autologous tissue, thus rendering the harvesting of autologous tissue unnecessary and significantly simplifying the shell technique. With the use of maxgraft® cortico®, patient’s discomfort, extraction morbidity, and operation time are significantly reduced.

mucoderm® soft tissue punch is a natural type I/III collagen matrix derived from porcine dermis that was specifically developed as an alternative to autologous soft tissue grafting for use in the socket seal technique. The closure of the alveolus with mucoderm® punch stabilizes the blood coagulum, protects the alveolus from contaminations, and supports the preservation of the soft tissue contour.

collacone® max is an innovative, biomimetic composite cone designed for socket preservation, which supports the osseous regeneration of the alveolus and prevents soft tissue collapse.

“Starting from defining the challenge and the clinical indication, botiss biomaterials pursues a path that translates findings in research and development into functional and rational solutions. Our goal is: ‘to establish innovation and to set new standards’,” explains the managing Director Dr. Drazen Tadic.

botiss biomaterials
Berlin-based botiss biomaterials GmbH is the second largest European company in the oral tissue regeneration field and acts as a trusted link between clinicians, researchers, and developers. botiss’ broad range of clinically proved high-quality solutions include a complete selection of bovine, allogenic, and synthetic bone substitute materials, membranes for soft/hard tissue regeneration, and products for soft tissue augmentation. The excellent quality of these biomaterials, demonstrated by solid clinical evidence, makes these biomaterials the products of choice of worldwide leading dental clinics. Besides the soft tissue products, botiss biomaterials is very proud to present other innovations such as the allograft bone ring, which is used for a simultaneous bone augmentation and an implant.
Contact Information
botiss biomaterials
Lasse Walter
+49 33769 8841985

Click here to view the list of recent Press Releases from botiss dental GmbH
Promote Your Business